1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine,
AZD6094,
HMPL-504,
savolitinib,
volitinib,
Savolitinib,
Volitinib,
1313725-88-0,
AZD-6094,
HMPL-504,
AZD6094,
HMPL504,
UNII-2A2DA6857R,
CHEMBL3334567,
2A2DA6857R,
Savolitinib [INN],
AZD6094, HMPL-504,
Volitinib(Savolitinib),
Savolitinib (USAN/INN),
Savolitinib [USAN:INN],
GTPL9918,
SCHEMBL12489208,
EX-A845,
3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine,
BDBM50023342,
MFCD28359096,
AKOS030526403,
ZINC149738712,
DB12048,
SB16823,
compound 28 [PMID: 25148209],
NCGC00475727-01,
1H-1,2,3-Triazolo(4,5-b)pyrazine, 1-((1S)-1-imidazo(1,2-a)pyridin-6-ylethyl)-6-(1-methyl-1H-pyrazol-4-yl)-,
AS-35250,
HY-15959,
FT-0700162,
Savolitinib;Volitinib;HMPL-504;AZD-6094,
A14419,
D11139,
J-690125,
(3E)-5-Chloro-3-[(5-{3-[(4-methyl-1,4-diazepan-1-yl)carbonyl]phenyl}-2-furyl)methylene]-1,3-dihydro-2H-indol-2-one hydrochloride,
(S)-1-(1-(imidazo[1,2-a]pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine,
4-{1-[(1S)-1-{imidazo[1,2-a]pyridin-6-yl}ethyl]-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl}-1-methyl-1H-pyrazole,
CS-4062,